Liver Disease & Gastroenterology

Liver disease & gastroenterology

We are currently conducting clinical studies of non-alcoholic fatty liver disease in Type 2 diabetes, outcome of antiviral treatment of hepatitis B and hepatitis C, as well as laboratory investigation into the mechanisms and hepatoprotective therapies for ischemiareperfusion injury to the liver, pathogenesis of non-alcoholic steatohepatitis (NASH) and liver cancer.

Our gastroenterology research focuses on understanding the mechanisms underlying ulcerative colitis, irritable bowel syndrome and Crohn's disease. We are particularly interested in the interplay between gut and microbes and the host immune system. 

Updated:  25 November 2017/Responsible Officer:  Dean, Medical School/Page Contact:  Webmaster, Medical School